Media Summary: Excerpt from the December 2020 ICARE Genetics Case Conferences outlining Excerpt from the August 2021 ICARE Genetics Case Conferences outlining Dr. Reznicek, a urologist in Bellingham, WA, goes over treatment options for prostate cancer based on recommendations from the ...

Nccn Guideline Updates V 2 - Detailed Analysis & Overview

Excerpt from the December 2020 ICARE Genetics Case Conferences outlining Excerpt from the August 2021 ICARE Genetics Case Conferences outlining Dr. Reznicek, a urologist in Bellingham, WA, goes over treatment options for prostate cancer based on recommendations from the ... Excerpt from the November 2025 ICARE Genetics Case Conference during which ICARE Principal Investigator, Dr. Tuya Pal, ... Excerpt from the July 2025 ICARE Genetics Case Conference during which ICARE Principal Investigator, Dr. Tuya Pal, outlines ... David Ilson, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses the comparability of CPS

In this empowering video, we dive deep into the National Comprehensive Cancer Network ( Gina Columbus reports on a priority review designation in prostate cancer, a breakthrough therapy designation in bladder cancer, ... Excerpt from the October 2022 ICARE Genetics Case Conference with ICARE's principal investigator, Dr. Tuya Pal, outlining ... MPN Horizons 2019 - Lisbon, Portugal Medical Session

Photo Gallery

NCCN Guideline Updates (V.2.2021)
NCCN Guideline Updates (V.1.2022)
Treatment Options for Clinically Localized Prostate Cancer - NCCN Recommendations
NCCN Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, & Prostate (Version 2.2026)
NCCN Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, & Prostate (Version 1.2026)
Checkpoint inhibitor use and scoring updates in gastric cancer: NCCN guidance and new approvals
“Using NCCN Guidelines in Cancer Management: A Practical Guide for Medical Students”
2024 Metastatic Urothelial Carcinoma Guidelines: NCCN, EAU, ESMO
Priority Reviews in Prostate and Bladder Cancer, NCCN CRC Guidelines Update, and More
How National Comprehensive Cancer Network (NCCN) Guidelines Help Pick the Best Myeloma Treatment
Prof William | NCCN Guidelines Version 2 2022 Invasive Breast Cancer
NCCN Genetic/Familial Guideline Updates (V1.2023 & V.1.2022)
Sponsored
Sponsored
View Detailed Profile
NCCN Guideline Updates (V.2.2021)

NCCN Guideline Updates (V.2.2021)

Excerpt from the December 2020 ICARE Genetics Case Conferences outlining

NCCN Guideline Updates (V.1.2022)

NCCN Guideline Updates (V.1.2022)

Excerpt from the August 2021 ICARE Genetics Case Conferences outlining

Sponsored
Treatment Options for Clinically Localized Prostate Cancer - NCCN Recommendations

Treatment Options for Clinically Localized Prostate Cancer - NCCN Recommendations

Dr. Reznicek, a urologist in Bellingham, WA, goes over treatment options for prostate cancer based on recommendations from the ...

NCCN Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, & Prostate (Version 2.2026)

NCCN Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, & Prostate (Version 2.2026)

Excerpt from the November 2025 ICARE Genetics Case Conference during which ICARE Principal Investigator, Dr. Tuya Pal, ...

NCCN Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, & Prostate (Version 1.2026)

NCCN Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, & Prostate (Version 1.2026)

Excerpt from the July 2025 ICARE Genetics Case Conference during which ICARE Principal Investigator, Dr. Tuya Pal, outlines ...

Sponsored
Checkpoint inhibitor use and scoring updates in gastric cancer: NCCN guidance and new approvals

Checkpoint inhibitor use and scoring updates in gastric cancer: NCCN guidance and new approvals

David Ilson, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses the comparability of CPS

“Using NCCN Guidelines in Cancer Management: A Practical Guide for Medical Students”

“Using NCCN Guidelines in Cancer Management: A Practical Guide for Medical Students”

In this empowering video, we dive deep into the National Comprehensive Cancer Network (

2024 Metastatic Urothelial Carcinoma Guidelines: NCCN, EAU, ESMO

2024 Metastatic Urothelial Carcinoma Guidelines: NCCN, EAU, ESMO

Join us

Priority Reviews in Prostate and Bladder Cancer, NCCN CRC Guidelines Update, and More

Priority Reviews in Prostate and Bladder Cancer, NCCN CRC Guidelines Update, and More

Gina Columbus reports on a priority review designation in prostate cancer, a breakthrough therapy designation in bladder cancer, ...

How National Comprehensive Cancer Network (NCCN) Guidelines Help Pick the Best Myeloma Treatment

How National Comprehensive Cancer Network (NCCN) Guidelines Help Pick the Best Myeloma Treatment

What are the

Prof William | NCCN Guidelines Version 2 2022 Invasive Breast Cancer

Prof William | NCCN Guidelines Version 2 2022 Invasive Breast Cancer

Cancer Research

NCCN Genetic/Familial Guideline Updates (V1.2023 & V.1.2022)

NCCN Genetic/Familial Guideline Updates (V1.2023 & V.1.2022)

Excerpt from the October 2022 ICARE Genetics Case Conference with ICARE's principal investigator, Dr. Tuya Pal, outlining ...

15. Guidelines update: National Comprehensive Cancer Network (NCCN)

15. Guidelines update: National Comprehensive Cancer Network (NCCN)

MPN Horizons 2019 - Lisbon, Portugal Medical Session